PRKN and malignant colon neoplasm: In the mitochondrial degradation pathway and PRKN (parkin RBR E3 ubiquitin protein ligase)-mediated mitophagy throughout the maturation phase of reticulocytes. Can inhibit MTORC1 to cause hypoxia colon cancer, brain ischemia, and autophagy